{
    "nctId": "NCT03833726",
    "briefTitle": "Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment",
    "officialTitle": "Light Emitting Diode for the Treatment of Genitourinary Syndrome of Menopause Associated With Hormonal Therapy for Treating Breast Cancer: Randomized Controlled Clinical Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Atrophy;Vaginal, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 77,
    "primaryOutcomeMeasure": "Vaginal maturation index",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18-65 anos\n* Pathological proven Breast Cancer diagnosis\n* Stage 0-III by American Joint Committee on Cancer (AJCC) and International Union Against Cancer (UICC) of Classification of Malignant Tumours, TNM (Acronym for Tumor-Node-Metastasis) 8\u00aa edition\n* Genitourinary Syndrome of Menopause confirmed through patient-reported symptoms and gynecological examination (of external structures, introitus, and vaginal mucosa)\n* Vaginal pH \\>5,0\n\nExclusion Criteria:\n\n* Hormone replacement less than 6 months\n* Diagnosis of vaginal infection\n* Difficulty in understanding the proposed instruments\n* Patients with chronic neurological degenerative diseases that preclude to be on position\n* Metastatic disease\n* Any vaginal photodynamic treatment less than 3 months",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}